Masimo (MASI) Sues Politan for Misstatements, Delays Annual Meet

Reasons Behind the Litigation The company's shares have lost 6.3% year to date against 4.3% growth of the industry. The S&P 500 has increased 16.9% during the same time frame. The conflict between Masimo and Politan has been a protracted one, centered around Politan's efforts to unseat CEO Joe Kiani. Last year, Politan secured two seats on Masimo's board. In a letter dated Jun 26, COO Bilal Muhsin expressed his intention to resign if Koffey and Politan gain control of the company. Nearly 300 Masimo Healthca ...